Table 2. The histological healing scores and inflammation scores of fracture sites at two and six weeks in the control, V5 (Vardenafil 5 mg) and V10 (Vardenafil 10 mg) groups.
| 2nd week | 6th week | p value | |
| Mean±SE | Mean±SE | ||
| Histological healing score | |||
| Control group | 1.17±0.41 | 6.50±0.84¶ | 0.0024 |
| V5 group | 4.83±1.60** | 7.67±1.51† | 0.0193 |
| V10 group | 4.67±2.07** | 8.67±0.82*,‡ | 0.0055 |
| p value | 0.0011 | 0.013 | |
| Inflammation score | |||
| Control group | 3.00±0.0 | 0.67±0.21¶ | 0.0001 |
| V5 group | 0.17±0.17*** | 0.17±0.17 | 1.00 |
| V10 group | 1.00±0.44*** | 0±0* | 0.076 |
| p value | <0.0001 | 0.045 | |
| BMD: Bone mineral density; SE: Standard error; * p<0.05; ** p<0.01 and *** p<0.001 vs control group; † p<0.05; ‡ p<0.01 and ¶ p<0.001 vs 2nd week group. | |||